-
The FDA has approved prasugrel, a new oral antiplatelet agent for use in preventing thrombosis in patients with acute coronary syndrome who are to be managed by angioplasty.
-
The anti-arrhythmic dronedarone has been approved by the FDA for maintenance of normal sinus rhythm in patients with a history of atrial fibrillation or atrial flutter.
-
The FDA has recently issued stronger warnings on a number of commonly used drugs:
-
-
Hand trauma is common, and children frequently present to the emergency department (ED) with these injuries.
-
-
If you had to name something that costs American businesses an estimated $4.1 billion a year in direct medical and mental health care services, would you think of intimate partner violence?
-
Coronary artery disease, diabetes, asthma, chronic obstructive pulmonary disease, and congestive heart failure. Would it surprise you to learn that emotional disorders cost companies more than any of these conditions?
-
New Spanish-language consumer guides have been released by the Agency for Healthcare Research and Quality (AHRQ).
-
"I know John's son and wife have the flu, but John doesn't look sick, and I really need him to complete that report." As an occupational health professional, you can expect to hear many statements like this if H1N1 returns this fall as expected.
